Cargando…

Dual Inhibition of PARP and the Intra-S/G2 Cell Cycle Checkpoints Results in Highly Effective Radiosensitization of HPV-Positive HNSCC Cells

In head and neck squamous cell carcinoma (HNSCC), tumors positive for human papillomavirus (HPV) represent a distinct biological entity with favorable prognosis. An enhanced radiation sensitivity of these tumors is evident in the clinic and on the cellular level when comparing HPV-positive and HPV-n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hintelmann, Katharina, Berenz, Thomas, Kriegs, Malte, Christiansen, Sabrina, Gatzemeier, Fruzsina, Struve, Nina, Petersen, Cordula, Betz, Christian, Rothkamm, Kai, Oetting, Agnes, Rieckmann, Thorsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329549/ https://www.ncbi.nlm.nih.gov/pubmed/34354944 http://dx.doi.org/10.3389/fonc.2021.683688

Ejemplares similares

Impaired DNA double-strand break repair and effective radiosensitization of HPV-negative HNSCC cell lines through combined inhibition of PARP and Wee1
por: Oetting, Agnes, et al.
Publicado: (2023)

Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines
por: Busch, Chia-Jung, et al.
Publicado: (2016)

G2 checkpoint targeting via Wee1 inhibition radiosensitizes EGFRvIII-positive glioblastoma cells
por: Cetin, Meryem H., et al.
Publicado: (2023)

Improving the Efficacy of Tumor Radiosensitization Through Combined Molecular Targeting
por: Hintelmann, Katharina, et al.
Publicado: (2020)

Radiosensitization of HNSCC cells by EGFR inhibition depends on the induction of cell cycle arrests
por: Kriegs, Malte, et al.
Publicado: (2016)

A Lack of Effectiveness in the ATM-Orchestrated DNA Damage Response Contributes to the DNA Repair Defect of HPV-Positive Head and Neck Cancer Cells
por: Köcher, Sabrina, et al.
Publicado: (2022)

Analyzing expression and phosphorylation of the EGF receptor in HNSCC
por: Kriegs, Malte, et al.
Publicado: (2019)

EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cells
por: Struve, Nina, et al.
Publicado: (2015)

The inflammation-reducing compatible solute ectoine does not impair the cytotoxic effect of ionizing radiation on head and neck cancer cells
por: Rieckmann, Thorsten, et al.
Publicado: (2019)

Roscovitine strongly enhances the effect of olaparib on radiosensitivity for HPV neg. but not for HPV pos. HNSCC cell lines
por: Ziemann, Frank, et al.
Publicado: (2017)

The failure of cetuximab-based de-intensified regimes for HPV-positive OPSCC: A radiobiologists perspective
por: Rieckmann, Thorsten, et al.
Publicado: (2019)

MEDB-50. Assessment of cellular radiosensitivity and DNA repair in medulloblastoma cell lines and patient-derivded xenograft slice cultures
por: Feyerabend, Simon, et al.
Publicado: (2022)

PARP1 inhibition radiosensitizes HNSCC cells deficient in homologous recombination by disabling the DNA replication fork elongation response
por: Wurster, Stephanie, et al.
Publicado: (2016)

Sorafenib inhibits cell growth but fails to enhance radio- and chemosensitivity of glioblastoma cell lines
por: Riedel, Matthias, et al.
Publicado: (2016)

Increased replication stress and R-loop accumulation in EGFRvIII-expressing glioblastoma present new therapeutic opportunities
por: Struve, Nina, et al.
Publicado: (2021)

Mass Spectrometric Comparison of HPV-Positive and HPV-Negative Oropharyngeal Cancer
por: Wurlitzer, Marcus, et al.
Publicado: (2020)

Tissue Microarray Analyses Suggest Axl as a Predictive Biomarker in HPV-Negative Head and Neck Cancer
por: Busch, Chia-Jung, et al.
Publicado: (2022)

Analyzing the influence of kinase inhibitors on DNA repair by differential proteomics of chromatin-interacting proteins and nuclear phospho-proteins
por: Gleißner, Lisa, et al.
Publicado: (2017)

Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells
por: Möckelmann, Nikolaus, et al.
Publicado: (2016)

Crosstalk between immune checkpoint and DNA damage response inhibitors for radiosensitization of tumors
por: Classen, Sandra, et al.
Publicado: (2023)

The Impact of YRNAs on HNSCC and HPV Infection
por: Guglas, Kacper, et al.
Publicado: (2023)

DNA Damage Response during Replication Correlates with CIN70 Score and Determines Survival in HNSCC Patients
por: Bold, Ioan T., et al.
Publicado: (2021)

Preferential targeting of cancer stem cells in the radiosensitizing effect of ABT-737 on HNSCC
por: Gilormini, Marion, et al.
Publicado: (2016)

Establishment of a Transformation Coupled in vitro End Joining Assay to Estimate Radiosensitivity in Tumor Cells
por: Degenhardt, Sarah, et al.
Publicado: (2020)

EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma
por: Struve, Nina, et al.
Publicado: (2020)

Radiotherapeutic Strategies to Overcome Resistance of Breast Cancer Brain Metastases by Considering Immunogenic Aspects of Cancer Stem Cells
por: Hintelmann, Katharina, et al.
Publicado: (2022)

The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma
por: Borgmann, Mara, et al.
Publicado: (2022)

Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells
por: Grottker, Fridolin, et al.
Publicado: (2023)

Pulsed Low Dose-rate Irradiation Response in Isogenic HNSCC Cell Lines with Different Radiosensitivity
por: Todorovic, Vesna, et al.
Publicado: (2020)

In Vitro Analysis of Superparamagnetic Iron Oxide Nanoparticles Coated with APTES as Possible Radiosensitizers for HNSCC Cells
por: Emer, Clara, et al.
Publicado: (2023)

Impaired 53BP1/RIF1 DSB mediated end-protection stimulates CtIP-dependent end resection and switches the repair to PARP1-dependent end joining in G1
por: Bakr, Ali, et al.
Publicado: (2016)

PARP inhibition and the radiosensitizing effects of the PARP inhibitor ABT-888 in in vitro hepatocellular carcinoma models
por: Guillot, Clément, et al.
Publicado: (2014)

Cyclin A1 shows age-related expression in benign tonsils, HPV16-dependent overexpression in HNSCC and predicts lower recurrence rate in HNSCC independently of HPV16
por: Weiss, Daniel, et al.
Publicado: (2012)

Exploiting Chromosomal Instability of PTEN-Deficient Triple-Negative Breast Cancer Cell Lines for the Sensitization Against PARP1 Inhibition in a Replication-Dependent Manner
por: Rieckhoff, Johanna, et al.
Publicado: (2020)

Second-Generation Antiandrogen Therapy Radiosensitizes Prostate Cancer Regardless of Castration State through Inhibition of DNA Double Strand Break Repair
por: Elsesy, Mohamed E., et al.
Publicado: (2020)

Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts
por: Koi, Lydia, et al.
Publicado: (2023)

HPV-16 infection modifies overall survival of Puerto Rican HNSCC patients
por: Rivera-Peña, Bianca, et al.
Publicado: (2016)

mTOR inhibition as an adjuvant therapy in a metastatic model of HPV+ HNSCC
por: Coppock, Joseph D., et al.
Publicado: (2016)

Expressed HNSCC variants by HPV-status in a well-characterized Michigan cohort
por: Qin, Tingting, et al.
Publicado: (2018)

HPV impacts survival of stage IVC non-oropharyngeal HNSCC cancer patients
por: Burr, Adam R, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o4958j1vfqbv8bi2o87b4dkhte